Relmada Therapeutics, Inc.
RLMD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001553643
In the last 90 days, Relmada Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $693.7M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Relmada Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 82 | 85 | +3 |
| Shares | 9.54M | 9.94M | +407.7K (+4.3%) |
| Value | $335.7M | $318.3M | −$17.4M (−5.2%) |
New holders (9)
Institutions that held Relmada Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Baker Bros. Advisors LP | 76,600 | $2.45M | 0.01% |
| Mangrove Partners | 46,976 | $1.50M | 0.17% |
| Silverarc Capital Management, LLC | 46,729 | $1.50M | 0.79% |
| ACT Capital Management, LLC | 24,700 | $791.0K | 0.41% |
| Jane Street Group, LLC | 18,919 | $606.0K | 0.00% |
| Dimensional Fund Advisors LP | 12,965 | $415.0K | 0.00% |
| Weiss Multi-Strategy Advisers LLC | 7,043 | $225.0K | 0.01% |
| STRS Ohio | 5,200 | $166.0K | 0.00% |
| Retirement Group, LLC | 5 | $0 | 0.00% |
Sold out (6)
Institutions that held Relmada Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Commodore Capital LP | 161,565 | $5.69M |
| California Public Employees Retirement System | 29,400 | $1.03M |
| Voya Investment Management LLC | 7,064 | $249.0K |
| Occudo Quantitative Strategies LP | 5,708 | $201.0K |
| Parallax Volatility Advisers, L.P. | 3,670 | $129.0K |
| Bank of Montreal | 429 | $15.0K |